The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
@article{Wright2015TheDO, title={The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases}, author={J. Wright and Leen H. Kawas and J. Harding}, journal={Progress in Neurobiology}, year={2015}, volume={125}, pages={26-46} }
Alzheimer's (AD) and Parkinson's (PD) diseases are neurodegenerative diseases presently without effective drug treatments. AD is characterized by general cognitive impairment, difficulties with memory consolidation and retrieval, and with advanced stages episodes of agitation and anger. AD is increasing in frequency as life expectancy increases. Present FDA approved medications do little to slow disease progression and none address the underlying progressive loss of synaptic connections and… CONTINUE READING
Topics from this paper
37 Citations
Brain angiotensin II and angiotensin IV receptors as potential Alzheimer’s disease therapeutic targets
- Medicine
- GeroScience
- 2020
- 2
Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
- Medicine
- Journal of Alzheimer's disease : JAD
- 2020
Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease
- Medicine
- 2020
- PDF
Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson’s disease
- Medicine
- Expert opinion on investigational drugs
- 2017
- 13
Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease
- Medicine
- Current neuropharmacology
- 2016
- 26
- PDF
Neurovascular and Cognitive failure in Alzheimer’s Disease: Benefits of Cardiovascular Therapy
- Medicine
- Cellular and Molecular Neurobiology
- 2015
- 29
Neuroprotective effects of geniposide on Alzheimer’s disease pathology
- Medicine
- Reviews in the neurosciences
- 2015
- 28
- PDF
References
SHOWING 1-10 OF 385 REFERENCES
Importance of the Brain Angiotensin System in Parkinson's Disease
- Medicine
- Parkinson's disease
- 2012
- 21
- PDF
The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease
- Medicine
- Journal of the renin-angiotensin-aldosterone system : JRAAS
- 2008
- 54
Angiotensin as a target for the treatment of Alzheimer’s disease, anxiety and depression
- Medicine
- Expert opinion on therapeutic targets
- 2004
- 88
Effects of centrally acting angiotensin converting enzyme inhibitors on functional decline in patients with Alzheimer's disease.
- Psychology, Medicine
- Journal of Alzheimer's disease : JAD
- 2014
- 59
- PDF
Is inhibition of the renin–angiotensin system a new treatment option for Alzheimer's disease?
- Medicine
- The Lancet Neurology
- 2007
- 168
The role of the central renin-angiotensin system in Parkinson’s disease
- Biology, Medicine
- Journal of the renin-angiotensin-aldosterone system : JRAAS
- 2010
- 63
- PDF
The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism.
- Medicine
- Current Alzheimer research
- 2005
- 219
Current treatment and recent clinical research in Alzheimer's disease.
- Medicine
- The Mount Sinai journal of medicine, New York
- 2010
- 70